Cadila buys JV partner's 50% stake in Zydus BSV Pharma

Financial details of the transaction are not known. Zydus BSV Pharma develops, manufactures and markets non-infringing and proprietary novel drug delivery system (NDDS) of approved anti-cancer agents for global markets.

Cadila Healthcare on Thursday acquired 50 percent stake from Bharat Serums and Vaccines in its JV firm, Zydus BSV Pharma, to make the unit a 100 percent subsidiary.

"The company has purchased 50 percent shares of Zydus BSV Pharma (Zydus BSV) from Bharat Serums and Vaccines and now Zydus BSV has become 100 percent subsidiary of Cadila Healthcare," Cadila Healthcare said in a BSE filing. Zydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).

It also offers contract manufacturing capabilities based on its modern facility and experience in the oncology injectable product manufacturing area.

Cadila Health stock price

On March 27, 2015, at 11:10 hrs Cadila Healthcare was quoting at Rs 1678.00, up Rs 16.75, or 1.01 percent. The 52-week high of the share was Rs 1760.00 and the 52-week low was Rs 928.20.

The company's trailing 12-month (TTM) EPS was at Rs 55.71 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 30.12. The latest book value of the company is Rs 177.28 per share. At current value, the price-to-book value of the company is 9.47.

Anda sedang membaca artikel tentang

Cadila buys JV partner's 50% stake in Zydus BSV Pharma

Dengan url

https://olahragakecantikan.blogspot.com/2015/03/cadila-buys-jv-partners-50-stake-in.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Cadila buys JV partner's 50% stake in Zydus BSV Pharma

namun jangan lupa untuk meletakkan link

Cadila buys JV partner's 50% stake in Zydus BSV Pharma

sebagai sumbernya

Olahraga Kecantikan